Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enzalutamide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02508636
What this trial is testing

Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer

Who this might be right for
Prostatic NeoplasmsPelvic Nodal
University of California, San Francisco 11
Testing effectiveness (Phase 2)WithdrawnNCT05191017
What this trial is testing

Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC

Who this might be right for
Prostate CancerProstatic CancerCancer of Prostate+5 more
Nuvation Bio Inc.
Testing effectiveness (Phase 2)Study completedNCT03939689
What this trial is testing

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate CancerProstatic Neoplasm+2 more
Progenics Pharmaceuticals, Inc. 120
Testing effectiveness (Phase 2)WithdrawnNCT02159690
What this trial is testing

A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy

Who this might be right for
Prostate CancerLocalized Prostate Cancer
Kenneth Pienta, MD
Early research (Phase 1)Study completedNCT02207504
What this trial is testing

Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 24
Large-scale testing (Phase 3)Active Not RecruitingNCT02446444
What this trial is testing

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University of Sydney 802
Early research (Phase 1)Study completedNCT01901133
What this trial is testing

Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group

Who this might be right for
Pharmacokinetics of MDV3100Healthy SubjectsKidney Diseases
Astellas Pharma Europe B.V. 33
Early research (Phase 1)Ended earlyNCT03829930
What this trial is testing

Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
George Washington University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT03246347
What this trial is testing

A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Wake Forest University Health Sciences 40
Early research (Phase 1)Study completedNCT02740985
What this trial is testing

Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-Small Cell Lung Cancer (NSCLC)Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)+1 more
AstraZeneca 313
Not applicableStudy completedNCT02677376
What this trial is testing

Imaging Biomarkers to Validate Response in Enzalutamide-Treated mCRPC

Who this might be right for
Prostatic Neoplasms
University of Wisconsin, Madison 7
Large-scale testing (Phase 3)Looking for participantsNCT07723248
What this trial is testing

Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
ORIC Pharmaceuticals 600
Testing effectiveness (Phase 2)Study completedNCT03002220
What this trial is testing

Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status

Who this might be right for
Prostate Cancer
MedSIR 52
Large-scale testing (Phase 3)Looking for participantsNCT06136624
What this trial is testing

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

Who this might be right for
Prostate Cancer Metastatic
Merck Sharp & Dohme LLC 1,310
Testing effectiveness (Phase 2)Looking for participantsNCT06499870
What this trial is testing

Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

Who this might be right for
Prostate Adenocarcinoma
Sean Sachdev 50
Testing effectiveness (Phase 2)Study completedNCT02057939
What this trial is testing

Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)

Who this might be right for
Prostate Cancer
Duke University 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07512076
What this trial is testing

A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer PatientsElderly PatientsPharmacokinetic Study
Sunnybrook Health Sciences Centre 26
Testing effectiveness (Phase 2)Study completedNCT02445976
What this trial is testing

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Who this might be right for
Prostate Cancer
Innocrin Pharmaceutical 197
Not applicableAvailableNCT05650476
What this trial is testing

Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pfizer
Large-scale testing (Phase 3)Ended earlyNCT02438007
What this trial is testing

Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC

Who this might be right for
Prostate Cancer
LTN PHARMACEUTICALS, INC. 953
Next Page